Zhang J M, Matsuura Y, Sueda T, Orihashi K, Fukunaga S, Watari M
First Department of Surgery, Hiroshima University School of Medicine, Japan.
Hiroshima J Med Sci. 1999 Jun;48(2):65-70.
Prevention of cardiac and vascular dysfunction with pretreatment has been accepted as an important factor in heart transplantation. Ginsenosides (GS) have been reported to have some beneficial effects on the cardiac and vascular system. We hypothesized that pretreatment with GS would result in an improvement of functional recovery after a 12 hour (hr) rat heart preservation. A Langendorff apparatus was applied to estimate the cardiac and vascular function in an isolated rat heart preparation. The hearts were preserved in University of Wisconsin solution at 0 degree C for 12 hr, after pretreatment with 0.9% sodium chloride or GS 100 mg/kg, respectively, in control (n = 9) and GS (n = 14) groups. After storage, the cardiac function, myocardial water content, and coronary vasodilatory response were evaluated. The GS group showed a significantly higher recovery percentage of cardiac function compared with the control group: aortic flow 81.4 +/- 21.4% versus 57.2 +/- 11.0% (p = 0.0052); coronary flow 81.4 +/- 14.5% versus 57.2 +/- 6.0% (p = 0.0001); +/- dp/dt max 72.5 +/- 16.1% and 66.0 +/- 16.1% versus 53.7 +/- 4.1% and 51.4 +/- 7.1% (p = 0.0027 and p = 0.0189) respectively. The GS group showed a lower increase in myocardial water content. With Langendorff perfusion, the endothelial and vascular smooth-muscle cell function were evaluated by an increasing percentage of coronary flow in response to acetylcholine chloride (0.3 x 10(-7) mol/liter) and nitroglycerin (0.5 x 10(-5) mol/liter). It was significantly higher in the GS group than that in the control group (19.2 +/- 8.8% and 28.0 +/- 14.1% versus 9.9 +/- 4.7% and 14.7 +/- 8.1%, p = 0.008 and p = 0.0187, respectively) at the first minute. These results suggest a protective effect on ventricular and coronary vascular function in the rats pretreated with Ginsenosides, indicating potential benefits for long-term heart preservation.
预处理预防心脏和血管功能障碍已被公认为心脏移植中的一个重要因素。据报道,人参皂苷(GS)对心脏和血管系统有一些有益作用。我们假设,用GS预处理将改善大鼠心脏保存12小时后的功能恢复。应用Langendorff装置评估离体大鼠心脏标本的心脏和血管功能。在对照组(n = 9)和GS组(n = 14)中,分别用0.9%氯化钠或100 mg/kg GS预处理后,心脏在威斯康星大学溶液中于0℃保存12小时。保存后,评估心脏功能、心肌含水量和冠状动脉舒张反应。与对照组相比,GS组心脏功能的恢复百分比显著更高:主动脉流量81.4±21.4% 对57.2±11.0%(p = 0.0052);冠状动脉流量81.4±14.5% 对57.2±6.0%(p = 0.0001);+/- dp/dt max分别为72.5±16.1%和66.0±16.1% 对53.7±4.1%和51.4±7.1%(p = 0.0027和p = 0.0189)。GS组心肌含水量的增加较低。通过Langendorff灌注,通过对氯化乙酰胆碱(0.3×10⁻⁷mol/L)和硝酸甘油(0.5×10⁻⁵mol/L)的冠状动脉流量增加百分比来评估内皮和血管平滑肌细胞功能。在第一分钟时,GS组显著高于对照组(分别为19.2±8.8%和28.0±14.1% 对9.9±4.7%和14.7±8.1%,p = 0.008和p = 0.0187)。这些结果表明,人参皂苷预处理对大鼠心室和冠状动脉血管功能有保护作用,表明对长期心脏保存有潜在益处。